Immediate Impact

2 from Science/Nature 49 standout
Sub-graph 1 of 24

Citing Papers

AASLD Practice Guideline on imaging-based noninvasive liver disease assessment of hepatic fibrosis and steatosis
2024 Standout
Resmetirom therapy for metabolic dysfunction-associated steatotic liver disease: October 2024 updates to AASLD Practice Guidance
2024 Standout
2 intermediate papers

Works of Yuji Kojima being referenced

Change in Fibrosis 4 Index as Predictor of High Risk of Incident Hepatocellular Carcinoma After Eradication of Hepatitis C Virus
2020
Increased lipid peroxidation in patients with non‐alcoholic fatty liver disease and chronic hepatitis C as measured by the plasma level of 8‐isoprostane
2006

Author Peers

Author Last Decade Papers Cites
Yuji Kojima 122 138 11 57 16 247
Davidson Cs 74 74 18 34 21 253
Joanna Pogorzelska 90 153 15 19 18 274
Naijuan Yao 116 139 12 27 31 244
Milica Bjelaković 178 206 8 20 11 285
Xiaoli Ma 62 130 7 22 24 262
Rui Huang 60 113 3 25 25 268
Mohammad Reza Deyhim 41 106 30 48 24 293
Luiz Carlos da Costa Gayotto 154 233 5 17 17 297
Claudine Saltiel 81 69 6 48 8 205
Alessia Giorgini 49 43 5 36 12 228

All Works

Loading papers...

Rankless by CCL
2026